TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
GRAL

GRAIL, LLC

Healthcare · Diagnostics & Research

108.50$ +0.5% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow GRAL
Line item 2018 2019 2020 2021 2022 2023 2024 2025
-4,709.3% -1,010.5% -639.9% -459.5% -203.2%
400.0% 278.6% 170.4% 125.8% 106.2%
4,666.8% 136.3% 104.4% 68.5% 39.6%
147.7% -26.0% 8.3% -19.3% 8.4%
478.6% 41.2% 13.8% 4.1% 0.6%
2,359.8% -41.2% -13.8% -438.7% -57.8%
-1.2% -7.5% -0.3%
2,701.5% 1,088.8% 498.1% 990.7% 287.6%
-979.9% 36.2% -155.3% 92.4% 26.6%
-5,187.9% -1,051.6% -653.8% -463.7% -203.2%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?